Cryo-Cell International, Inc. (CCEL)
USD 4.85
(-6.73%)
USD 4.85
(-6.73%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 35.2 Million USD | 13.62% |
| 2022 | 17.08 Million USD | 10.15% |
| 2021 | 15.51 Million USD | 7.08% |
| 2020 | 14.48 Million USD | -4.25% |
| 2019 | 15.12 Million USD | -4.89% |
| 2018 | 15.9 Million USD | 16.49% |
| 2017 | 13.65 Million USD | -8.55% |
| 2016 | 14.93 Million USD | 19.18% |
| 2015 | 12.52 Million USD | 0.32% |
| 2014 | 12.48 Million USD | 7.74% |
| 2013 | 11.59 Million USD | -21.37% |
| 2012 | 14.74 Million USD | 11.93% |
| 2011 | 13.16 Million USD | 32.85% |
| 2010 | 9.91 Million USD | -2.07% |
| 2009 | 10.12 Million USD | -11.45% |
| 2008 | 11.43 Million USD | -26.45% |
| 2007 | 15.54 Million USD | 10.43% |
| 2006 | 14.07 Million USD | 54.91% |
| 2005 | 9.08 Million USD | 54.82% |
| 2004 | 5.86 Million USD | -52.86% |
| 2003 | 12.44 Million USD | 23.06% |
| 2002 | 10.11 Million USD | 125.87% |
| 2001 | 4.47 Million USD | 30.07% |
| 2000 | 3.44 Million USD | 37.72% |
| 1999 | 2.5 Million USD | 0.0% |
| 1998 | 2.5 Million USD | 19.05% |
| 1997 | 2.1 Million USD | 31.25% |
| 1996 | 1.6 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 4.87 Million USD | -20.3% |
| 2024 Q2 | 4.32 Million USD | -11.35% |
| 2024 Q3 | 4.53 Million USD | 5.29% |
| 2023 Q2 | 4.62 Million USD | 9.11% |
| 2023 Q1 | 4.23 Million USD | -15.97% |
| 2023 Q4 | 6.11 Million USD | 38.1% |
| 2023 FY | 19.41 Million USD | 13.62% |
| 2023 Q3 | 4.42 Million USD | -4.21% |
| 2022 Q3 | 3.96 Million USD | -7.2% |
| 2022 FY | 17.08 Million USD | 10.15% |
| 2022 Q1 | 3.8 Million USD | -21.73% |
| 2022 Q2 | 4.27 Million USD | 12.42% |
| 2022 Q4 | 5.04 Million USD | 27.2% |
| 2021 Q1 | 3.46 Million USD | -2.05% |
| 2021 Q4 | 4.85 Million USD | 28.72% |
| 2021 Q2 | 3.41 Million USD | -1.21% |
| 2021 FY | 15.51 Million USD | 7.08% |
| 2021 Q3 | 3.77 Million USD | 10.36% |
| 2020 Q4 | 3.53 Million USD | 3.33% |
| 2020 Q2 | 3.61 Million USD | -7.86% |
| 2020 Q1 | 3.91 Million USD | -2.13% |
| 2020 FY | 14.48 Million USD | -4.25% |
| 2020 Q3 | 3.41 Million USD | -5.32% |
| 2019 Q4 | 4 Million USD | 11.06% |
| 2019 Q2 | 3.7 Million USD | -2.62% |
| 2019 Q3 | 3.6 Million USD | -2.75% |
| 2019 Q1 | 3.8 Million USD | -9.37% |
| 2019 FY | 15.12 Million USD | -4.89% |
| 2018 Q3 | 4.46 Million USD | 24.07% |
| 2018 FY | 15.9 Million USD | 16.49% |
| 2018 Q4 | 4.2 Million USD | -5.89% |
| 2018 Q2 | 3.59 Million USD | -1.12% |
| 2018 Q1 | 3.63 Million USD | 1.36% |
| 2017 FY | 13.65 Million USD | -8.55% |
| 2017 Q2 | 3.45 Million USD | 9.8% |
| 2017 Q3 | 3.46 Million USD | 0.4% |
| 2017 Q4 | 3.59 Million USD | 3.58% |
| 2017 Q1 | 3.14 Million USD | -18.51% |
| 2016 Q1 | 3.64 Million USD | -6.1% |
| 2016 Q3 | 3.96 Million USD | 14.61% |
| 2016 Q2 | 3.45 Million USD | -5.15% |
| 2016 Q4 | 3.85 Million USD | -2.69% |
| 2016 FY | 14.93 Million USD | 19.18% |
| 2015 Q1 | 2.94 Million USD | -15.44% |
| 2015 Q2 | 3.03 Million USD | 3.06% |
| 2015 Q3 | 2.66 Million USD | -12.2% |
| 2015 FY | 12.52 Million USD | 0.32% |
| 2015 Q4 | 3.88 Million USD | 45.8% |
| 2014 FY | 12.48 Million USD | 7.74% |
| 2014 Q3 | 3 Million USD | 6.89% |
| 2014 Q4 | 3.48 Million USD | 15.7% |
| 2014 Q2 | 2.81 Million USD | -11.52% |
| 2014 Q1 | 3.18 Million USD | 8.56% |
| 2013 FY | 11.59 Million USD | -21.37% |
| 2013 Q1 | 2.75 Million USD | -30.96% |
| 2013 Q2 | 3.01 Million USD | 9.38% |
| 2013 Q3 | 2.88 Million USD | -4.28% |
| 2013 Q4 | 2.93 Million USD | 1.52% |
| 2012 Q1 | 3.23 Million USD | 26.27% |
| 2012 FY | 14.74 Million USD | 11.93% |
| 2012 Q4 | 3.99 Million USD | 25.68% |
| 2012 Q3 | 3.17 Million USD | -26.74% |
| 2012 Q2 | 4.33 Million USD | 34.22% |
| 2011 Q1 | 2.62 Million USD | -0.69% |
| 2011 Q3 | 5.11 Million USD | 78.46% |
| 2011 FY | 13.16 Million USD | 32.85% |
| 2011 Q4 | 2.55 Million USD | -49.98% |
| 2011 Q2 | 2.86 Million USD | 9.2% |
| 2010 Q2 | 2.36 Million USD | -3.28% |
| 2010 Q3 | 2.45 Million USD | 3.74% |
| 2010 Q1 | 2.44 Million USD | -20.87% |
| 2010 Q4 | 2.64 Million USD | 7.69% |
| 2010 FY | 9.91 Million USD | -2.07% |
| 2009 Q3 | 2.46 Million USD | 5.1% |
| 2009 Q1 | 2.22 Million USD | -11.1% |
| 2009 Q2 | 2.34 Million USD | 5.56% |
| 2009 Q4 | 3.09 Million USD | 25.48% |
| 2009 FY | 10.12 Million USD | -11.45% |
| 2008 Q4 | 2.49 Million USD | -14.38% |
| 2008 Q1 | 2.88 Million USD | -24.51% |
| 2008 Q2 | 3.18 Million USD | 10.3% |
| 2008 Q3 | 2.91 Million USD | -8.33% |
| 2008 FY | 11.43 Million USD | -26.45% |
| 2007 Q4 | 3.82 Million USD | -1.82% |
| 2007 FY | 15.54 Million USD | 10.43% |
| 2007 Q1 | 3.52 Million USD | -8.99% |
| 2007 Q2 | 4.29 Million USD | 21.95% |
| 2007 Q3 | 3.89 Million USD | -9.41% |
| 2006 Q3 | 3.96 Million USD | 8.99% |
| 2006 Q4 | 3.87 Million USD | -2.34% |
| 2006 Q2 | 3.63 Million USD | 40.19% |
| 2006 Q1 | 2.59 Million USD | 17.97% |
| 2006 FY | 14.07 Million USD | 54.91% |
| 2005 Q1 | 2.15 Million USD | 0.99% |
| 2005 Q2 | 2.73 Million USD | 27.13% |
| 2005 Q4 | 2.2 Million USD | 10.11% |
| 2005 Q3 | 1.99 Million USD | -26.94% |
| 2005 FY | 9.08 Million USD | 54.82% |
| 2004 Q3 | 342.8 Thousand USD | -79.97% |
| 2004 Q1 | 1.68 Million USD | -74.6% |
| 2004 Q4 | 2.13 Million USD | 521.39% |
| 2004 Q2 | 1.71 Million USD | 1.88% |
| 2004 FY | 5.86 Million USD | -52.86% |
| 2003 Q3 | 2.12 Million USD | 7.5% |
| 2003 FY | 12.44 Million USD | 23.06% |
| 2003 Q1 | 1.72 Million USD | -64.72% |
| 2003 Q4 | 6.61 Million USD | 210.6% |
| 2003 Q2 | 1.98 Million USD | 15.0% |
| 2002 Q3 | 2.6 Million USD | 67.28% |
| 2002 Q1 | 1.06 Million USD | -29.72% |
| 2002 Q2 | 1.55 Million USD | 45.89% |
| 2002 FY | 10.11 Million USD | 125.87% |
| 2002 Q4 | 4.88 Million USD | 87.29% |
| 2001 Q4 | 1.51 Million USD | 45.99% |
| 2001 Q3 | 1.04 Million USD | 1.03% |
| 2001 Q2 | 1.03 Million USD | 14.1% |
| 2001 Q1 | 903.1 Thousand USD | -16.49% |
| 2001 FY | 4.47 Million USD | 30.07% |
| 2000 FY | 3.44 Million USD | 37.72% |
| 2000 Q4 | 1.08 Million USD | 23.82% |
| 2000 Q3 | 873.33 Thousand USD | 2.6% |
| 2000 Q2 | 851.16 Thousand USD | 35.29% |
| 2000 Q1 | 629.13 Thousand USD | 109.71% |
| 1999 Q2 | 600 Thousand USD | 20.0% |
| 1999 Q1 | 500 Thousand USD | -28.57% |
| 1999 Q4 | 300 Thousand USD | -70.0% |
| 1999 Q3 | 1 Million USD | 66.67% |
| 1999 FY | 2.5 Million USD | 0.0% |
| 1998 Q2 | 600 Thousand USD | 50.0% |
| 1998 FY | 2.5 Million USD | 19.05% |
| 1998 Q4 | 700 Thousand USD | 16.67% |
| 1998 Q3 | 600 Thousand USD | 0.0% |
| 1998 Q1 | 400 Thousand USD | -50.0% |
| 1997 Q4 | 800 Thousand USD | 100.0% |
| 1997 Q1 | 400 Thousand USD | 121.05% |
| 1997 Q2 | 400 Thousand USD | 0.0% |
| 1997 FY | 2.1 Million USD | 31.25% |
| 1997 Q3 | 400 Thousand USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | -1.9 Million USD | 0.0% |
| 1996 FY | 1.6 Million USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 79.998% |
| Addus HomeCare Corporation | 248.92 Million USD | 85.857% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | 70.246% |
| Amedisys, Inc. | 834.47 Million USD | 95.781% |
| Astrana Health, Inc. | 112.59 Million USD | 68.733% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 94.006% |
| IMAC Holdings, Inc. | 5.02 Million USD | -600.309% |
| biote Corp. | 98.82 Million USD | 64.376% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 89.575% |
| COMPASS Pathways plc | 136.91 Million USD | 74.287% |
| DocGo Inc. | 180.32 Million USD | 80.477% |
| The Ensign Group, Inc. | 335.39 Million USD | 89.503% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 81.382% |
| InnovAge Holding Corp. | 558.25 Million USD | 93.694% |
| The Joint Corp. | 109.22 Million USD | 67.767% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 92.833% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -92.99% |
| ModivCare Inc. | 586.89 Million USD | 94.001% |
| NewGenIvf Group Limited | 1.63 Million USD | -2047.27% |
| Option Care Health, Inc. | 666.62 Million USD | 94.719% |
| P3 Health Partners Inc. | 199.56 Million USD | 82.359% |
| P3 Health Partners Inc. | 199.56 Million USD | 82.359% |
| The Pennant Group, Inc. | 88.99 Million USD | 60.441% |
| Surgery Partners, Inc. | 319.5 Million USD | 88.981% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -718.826% |
| Talkspace, Inc. | 97.58 Million USD | 63.925% |
| Talkspace, Inc. | 97.58 Million USD | 63.925% |
| The Oncology Institute, Inc. | 136.59 Million USD | 74.226% |
| The Oncology Institute, Inc. | 136.59 Million USD | 74.226% |